Filtered By:
Infectious Disease: Tuberculosis
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 35529 results found since Jan 2013.
Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis
Conclusions Positive RISK11 signature status is often transient, possibly due to intercurrent viral infection, highlighting potentially important challenges for implementation of these biomarkers as new tools for TB control. This article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).PMID:34520313 | DOI:10.1164/rccm.202103-0548OC
Source: American Journal of Respiratory and Critical Care Medicine - September 14, 2021 Category: Respiratory Medicine Authors: Humphrey Mulenga Munyaradzi Musvosvi Simon C Mendelsohn Adam Penn-Nicholson Stanley Kimbung Mbandi Andrew-Fiore Gartland Mich èle Tameris Simbarashe Mabwe Hadn Africa Nicole Bilek Fazlin Kafaar Shabaana A Khader Balie Carstens Katie Hadley Chris Hikuam M Source Type: research
Effects of Curcuma longa L., Eucommia ulmoides Oliv. and Gynostemma pentaphyllum (Thunb.) Makino on Cytokine Production in Stimulated Peripheral Blood Mononuclear Cells in Patients with Tuberculosis
CONCLUSION: These results show that G pentaphyllum (Thunb.) Makino might enhance cell immunity since it increased the production of IL-12 and TNF-α with dose effect.PMID:34559685
Source: Alternative Therapies in Health and Medicine - September 24, 2021 Category: Complementary Medicine Authors: Li-Pang Chuang Chien-Ming Chu Han-Chung Hu Yin-Ku Lin Kuo-Chin Kao Huang-Pin Wu Source Type: research
Analysis of the Mechanism of Action of Kushen in the Treatment of Tuberculosis Based on Network Pharmacology
CONCLUSIONS: The network pharmacology analysis showed that Kushen's active ingredients can play a role in the treatment of TB through the HIF-1 signaling pathway.PMID:36455142
Source: Alternative Therapies in Health and Medicine - December 1, 2022 Category: Complementary Medicine Authors: Min Lin Huan Zhou Rong Li Li-Li Quan Zhu Jin Xiao-Wei Tong Source Type: research
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
CONCLUSIONS: Pretomanid enhanced the microbiologic activity of rifamycin-pyrazinamide containing regimens. Efficacy and hepatic adverse events appeared highest with the pretomanid and rifabutin-containing regimen. Whether this is due to higher pretomanid concentrations merits exploration. Clinical trial registration available at www.CLINICALTRIALS: gov, ID: NCT02256696.PMID:36455068 | DOI:10.1164/rccm.202208-1475OC
Source: American Journal of Respiratory and Critical Care Medicine - December 1, 2022 Category: Respiratory Medicine Authors: Kelly E Dooley Bronwyn Hendricks Nikhil Gupte Grace Barnes Kim Narunsky Colleen Whitelaw Tanya Smit Elisa H Ignatius Adine Friedman Susan E Dorman Rodney Dawson Assessing Pretomanid for Tuberculosis (APT) Study Team Source Type: research
A151: Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Performance Improvement on Juvenile Idiopathic Arthritis Quality Measures
Conclusion:PR‐COIN sites are collectively and individually demonstrating significant improvements in JIA process of care QMs. Quality improvement efforts in PR‐COIN are ongoing with the goal of improving the outcome for patients with JIA.
Source: Arthritis and Rheumatism - March 27, 2014 Category: Rheumatology Authors: Julia G. Harris, Esi Morgan DeWitt, Ronald M. Laxer, Stacy P. Ardoin, Beth S. Gottlieb, Judyann C. Olson, Murray H. Passo, Jennifer E. Weiss, Daniel J. Lovell, Tzielan C. Lee, Sheetal S. Vora, Nancy Griffin, Jason A. Stock, Lynn M. Darbie, Catherine A. Bi Tags: Oral Presentations Source Type: research
Predictors of pulmonary critical care recidivism
Conclusion Age above 50years, obesity, non recovered AKI, presence of type II respiratory failure, nocturnal and hot day discharge, need for pressors and tracheostomy are considered to be predictors of recidivism to pulmonary critical care unit.
Source: Egyptian Journal of Chest Diseases and Tuberculosis - November 1, 2014 Category: Respiratory Medicine Source Type: research
Mycobacterial Lung Disease Complicating HIV Infection
Semin Respir Crit Care Med 2016; 37: 230-242DOI: 10.1055/s-0036-1572559Mycobacterial infections have caused enormous morbidity and mortality in people living with human immunodeficiency virus (HIV) infection. Of these, the most devastating has been tuberculosis (TB), the leading cause of death among HIV-positive persons globally. TB has killed more people living with HIV than any other infection. Diagnosis of latent TB infection (LTBI) is critical as treatment can prevent emergence of TB disease. Bacteriologic confirmation of TB disease should be sought whenever possible as well as drug susceptibility testing. When detecte...
Source: Seminars in Respiratory and Critical Care Medicine - March 14, 2016 Category: Respiratory Medicine Authors: Haas, Michelle K.Daley, Charles L. Source Type: research
Reply to: Subclinical Tuberculosis: Some Flies in the Ointment
Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202102-0367LE. Online ahead of print.NO ABSTRACTPMID:33689676 | DOI:10.1164/rccm.202102-0367LE
Source: American Journal of Respiratory and Critical Care Medicine - March 10, 2021 Category: Respiratory Medicine Authors: Emily A Kendall Sourya Shrestha David W Dowdy Source Type: research
Subclinical Tuberculosis: Some Flies in the Ointment
Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202101-0227LE. Online ahead of print.NO ABSTRACTPMID:33689597 | DOI:10.1164/rccm.202101-0227LE
Source: American Journal of Respiratory and Critical Care Medicine - March 10, 2021 Category: Respiratory Medicine Authors: Cameron W Pierce Source Type: research
Glycemic Trajectories After Tuberculosis Diagnosis and Treatment Outcomes of New Tuberculosis Patients: A Prospective Study in Eastern China
Conclusions Among tuberculosis patients without diabetes, glycemic changes were common and may represent an important marker for patient response to tuberculosis treatment.PMID:33705666 | DOI:10.1164/rccm.202007-2634OC
Source: American Journal of Respiratory and Critical Care Medicine - March 11, 2021 Category: Respiratory Medicine Authors: Qiao Liu Nannan You Hongqui Pan Ye Shen Peng Lu Jianming Wang Wei Lu Limei Zhu Leonardo Martinez Source Type: research
Reply to: Subclinical Tuberculosis: Some Flies in the Ointment
Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202102-0367LE. Online ahead of print.NO ABSTRACTPMID:33689676 | DOI:10.1164/rccm.202102-0367LE
Source: American Journal of Respiratory and Critical Care Medicine - March 10, 2021 Category: Respiratory Medicine Authors: Emily A Kendall Sourya Shrestha David W Dowdy Source Type: research
